Therapeutic targeting of STAT pathways in CNS autoimmune diseases. - Wikidata - wikimedia - TriplyDB

Therapeutic targeting of STAT pathways in CNS autoimmune diseases.

Therapeutic targeting of STAT pathways in CNS autoimmune diseases.

http://www.wikidata.org/entity/Q36895435

about

Redox control of microglial function: molecular mechanisms and functional significance Involvement of the janus kinase/signal transducer and activator of transcription signaling pathway in multiple sclerosis and the animal model of experimental autoimmune encephalomyelitis.Th17 pathway-mediated immunopathogenesis of schizophrenia: mechanisms and implications Topical administration of a suppressor of cytokine signaling-1 (SOCS1) mimetic peptide inhibits ocular inflammation and mitigates ocular pathology during mouse uveitis.Interleukin 12 (IL-12) family cytokines: Role in immune pathogenesis and treatment of CNS autoimmune disease.BJ-3105, a 6-Alkoxypyridin-3-ol Analog, Impairs T Cell Differentiation and Prevents Experimental Autoimmune Encephalomyelitis Disease Progression.Human parvovirus B19 VP1u Protein as inflammatory mediators induces liver injury in naïve mice SOCS1 Mimetic Peptide Suppresses Chronic Intraocular Inflammatory Disease (Uveitis).Regulation of interferon gamma signaling by suppressors of cytokine signaling and regulatory T cells.Th17 cells in immunity and autoimmunity.Small molecules as therapy for uveitis: a selected perspective of new and developing agents.Regulation of IFN-γ Expression.STAT signaling in inflammation Rifampicin attenuates experimental autoimmune encephalomyelitis by inhibiting pathogenic Th17 cells responses.BJ-2266 ameliorates experimental autoimmune encephalomyelitis through down-regulation of the JAK/STAT signaling pathway.Rare autoimmune disorders with Mendelian inheritance.Amelioration of Experimental autoimmune encephalomyelitis and DSS induced colitis by NTG-A-009 through the inhibition of Th1 and Th17 cells differentiation.

P2860

Q27000279-C0CC12E4-ACCD-4852-83E9-F023944A1DEF Q33988247-7ADD209E-0D8C-4FB5-AB27-A01FB4417EA8 Q34323034-B1EFEC2E-62F0-4EFB-931A-DCE06CAED781 Q35930484-939073D6-CB97-45E2-8BB6-245A615E820C Q36005974-B3138DDF-078D-46BB-B3FA-AE39B1E18FFB Q36251241-3459012C-8D02-4DD6-A578-3A4B720B2C76 Q37197356-65C89DCC-B425-4756-A187-FDB63A558847 Q37293409-14E31B69-C9D9-418F-BBEF-12C5E5ED3BC1 Q37400302-68F77FDC-12CD-4F69-A476-1EC258BB063B Q38181087-FC767EE7-EF77-4627-8F30-FEB96E5C1EA2 Q38650868-20DECBA6-E58B-4D13-ACB4-CF40C56FD084 Q38812169-502C43F5-E97C-4017-B428-0A0F3C2291E6 Q41392782-A9A5F97E-F272-48CC-A4CC-55877B03EC63 Q47970743-77A31953-B3DF-48ED-A162-18B3244A8CB5 Q48167881-01862D49-6410-4BAB-AFF3-F69533F6305D Q53086157-1E0C6729-4C1D-453C-84DE-9B673C3F9AAA Q55244957-326CDCE9-AFEC-4E0E-8515-4DA00A4689C9

P2860

Therapeutic targeting of STAT pathways in CNS autoimmune diseases.

http://www.wikidata.org/entity/Q36895435

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Therapeutic targeting of STAT pathways in CNS autoimmune diseases.

@en

type

label

Therapeutic targeting of STAT pathways in CNS autoimmune diseases.

@en

prefLabel

Therapeutic targeting of STAT pathways in CNS autoimmune diseases.

@en

P1433

Q36895435-00F3518A-27F2-4DD1-8F48-C4F317E8C6A7

P1476

Q36895435-C591A9EA-4B85-4C37-BCFA-468E735366E0

P2093

Q36895435-271AAD8A-8F9F-4605-83B2-CC25E9D09905

Q36895435-87AC522F-C50D-41DE-A102-1046D458A6BE

P2860

Q36895435-0760C0A8-C81C-4490-A544-78BC1F362ECE

Q36895435-0B7C30F9-CA29-461D-8BD0-6AAB94F895DD

Q36895435-0C2D44BE-003A-4C0A-8191-E3EAA7786BAB

Q36895435-10594A82-6DEC-4AEA-8313-47EBC2C9688D

Q36895435-176E80FC-93DA-4E67-B6B2-2E631BEAC82B

Q36895435-215B58AD-5BFE-49A9-9E81-B8F602C091D6

Q36895435-21F33438-1497-47EB-9A79-599177EBA3DF

Q36895435-2CF711CF-134A-4BCC-9010-F9B161599969

Q36895435-2EB4572A-5AD9-4101-8029-3F4FC9D039DE

Q36895435-3123179F-B767-455F-B81C-EF00E37F30EB

P304

Q36895435-BDA9446D-2CAC-442F-BEA0-28858182A771

P31

Q36895435-2BBE9D83-E018-4768-AD9A-5FF16C9559E6

P356

Q36895435-25CD5BC3-E088-42C3-BA46-A6C1166CCEAB

P433

Q36895435-C9453C37-4192-40C3-BCFB-8815CF145C0A

P478

Q36895435-70E6CB41-6C3A-47B3-A0A8-3B859842F610

P577

Q36895435-A753F4C3-D492-4A01-AA17-DE6096C3782C

P5875

Q36895435-73ADBC44-58B9-4383-A294-00D230AACC63

P698

Q36895435-3868BC1A-6CD4-49E6-BFDE-29E3B26EB0BF

P932

Q36895435-9CA79288-1472-4344-914F-DED94BD3DDAF

P356

P1433

P1476

Therapeutic targeting of STAT pathways in CNS autoimmune diseases.

@en

P2093

Charles E Egwuagu

http://www.w3.org/2001/XMLSchema#string

Joseph Larkin Iii

http://www.w3.org/2001/XMLSchema#string

P2860

Impaired development of CD4+ CD25+ regulatory T cells in the absence of STAT1: increased susceptibility to autoimmune disease.

A molecular trio in relapse and remission in multiple sclerosis

Therapeutic targeting of STAT3 (signal transducers and activators of transcription 3) pathway inhibits experimental autoimmune uveitis

Stats: transcriptional control and biological impact

STATs and gene regulation

Differentiation of effector CD4 T cell populations (*)

Genome-wide association study in a high-risk isolate for multiple sclerosis reveals associated variants in STAT3 gene.

Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis.

Signaling and transcription in T helper development.

Ocular immune privilege: therapeutic opportunities from an experiment of nature.

P304

e24134

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4161/JKST.24134

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2013-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

256932423

http://www.w3.org/2001/XMLSchema#string

P698

24058800

http://www.w3.org/2001/XMLSchema#string

P932

3670276

http://www.w3.org/2001/XMLSchema#string